{"id":"https://openalex.org/W4212902132","doi":"https://doi.org/10.3389/fimmu.2022.807271","title":"Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives","display_name":"Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives","alternate_titles":[],"publication_year":2022,"publication_date":"2022-01-31","ids":{"openalex":"https://openalex.org/W4212902132","doi":"https://doi.org/10.3389/fimmu.2022.807271","pmid":"https://pubmed.ncbi.nlm.nih.gov/35173722","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8841724"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2022.807271","doi":"https://doi.org/10.3389/fimmu.2022.807271","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2022.807271","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2022.807271/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4212902132"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2022.807271/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009157549","display_name":"Florent Peyraud","orcid":"https://orcid.org/0000-0001-7438-2847","observed_orcids":["https://orcid.org/0000-0001-7438-2847"]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I4210134409","display_name":"Institut Bergoni\u00e9","ror":"https://ror.org/02yw1f353","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210134409"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"Florent Peyraud","raw_affiliation_strings":["Department of Medical Oncology, Institut Bergoni\u00e9, Bordeaux, France","Early Phase Trials and Sarcoma Unit, Institut Bergoni\u00e9, Bordeaux, France","University of Bordeaux, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Bergoni\u00e9, Bordeaux, France","institution_ids":["https://openalex.org/I4210134409"]},{"raw_affiliation_string":"Early Phase Trials and Sarcoma Unit, Institut Bergoni\u00e9, Bordeaux, France","institution_ids":["https://openalex.org/I4210134409"]},{"raw_affiliation_string":"University of Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I15057530"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015113973","display_name":"Jean\u2010Philippe Gu\u00e9gan","orcid":"https://orcid.org/0000-0002-3993-0956","observed_orcids":["https://orcid.org/0000-0002-3993-0956"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Jean-Philippe Guegan","raw_affiliation_strings":["Explicyte, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Explicyte, Bordeaux, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053186914","display_name":"D. Bodet","orcid":"https://orcid.org/0000-0003-2227-0696","observed_orcids":["https://orcid.org/0000-0003-2227-0696"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"Dominique Bodet","raw_affiliation_strings":["Explicyte, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Explicyte, Bordeaux, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102750304","display_name":"Sophie Cousin","orcid":"https://orcid.org/0000-0002-4847-6329","observed_orcids":["https://orcid.org/0000-0002-4847-6329"]},"institutions":[{"id":"https://openalex.org/I4210134409","display_name":"Institut Bergoni\u00e9","ror":"https://ror.org/02yw1f353","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210134409"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"Sophie Cousin","raw_affiliation_strings":["Department of Medical Oncology, Institut Bergoni\u00e9, Bordeaux, France","Early Phase Trials and Sarcoma Unit, Institut Bergoni\u00e9, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Bergoni\u00e9, Bordeaux, France","institution_ids":["https://openalex.org/I4210134409"]},{"raw_affiliation_string":"Early Phase Trials and Sarcoma Unit, Institut Bergoni\u00e9, Bordeaux, France","institution_ids":["https://openalex.org/I4210134409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069010161","display_name":"Alban Bessede","orcid":"https://orcid.org/0000-0002-6521-8380","observed_orcids":["https://orcid.org/0000-0002-6521-8380"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Alban Bessede","raw_affiliation_strings":["Explicyte, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Explicyte, Bordeaux, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060949051","display_name":"Anto\u00eene Italiano","orcid":"https://orcid.org/0000-0002-8540-5351","observed_orcids":["https://orcid.org/0000-0002-8540-5351"]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I4210134409","display_name":"Institut Bergoni\u00e9","ror":"https://ror.org/02yw1f353","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210134409"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Antoine Italiano","raw_affiliation_strings":["Department of Medical Oncology, Institut Bergoni\u00e9, Bordeaux, France","Early Phase Trials and Sarcoma Unit, Institut Bergoni\u00e9, Bordeaux, France","University of Bordeaux, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Bergoni\u00e9, Bordeaux, France","institution_ids":["https://openalex.org/I4210134409"]},{"raw_affiliation_string":"Early Phase Trials and Sarcoma Unit, Institut Bergoni\u00e9, Bordeaux, France","institution_ids":["https://openalex.org/I4210134409"]},{"raw_affiliation_string":"University of Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I15057530"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5009157549"],"corresponding_institution_ids":["https://openalex.org/I15057530","https://openalex.org/I4210134409"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":3.3102,"has_fulltext":true,"cited_by_count":142,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.95524358,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"13","issue":null,"first_page":"807271","last_page":"807271"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6729000210762024,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6729000210762024,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.19419999420642853,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.04610000178217888,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tryptophan-catabolism","display_name":"tryptophan catabolism","score":0.996999979019165},{"id":"https://openalex.org/keywords/kynurenine-pathway","display_name":"kynurenine pathway","score":0.8560000061988831},{"id":"https://openalex.org/keywords/ido1-inhibitors","display_name":"IDO1 inhibitors","score":0.8149999976158142},{"id":"https://openalex.org/keywords/ido2","display_name":"IDO2","score":0.9520000219345093},{"id":"https://openalex.org/keywords/tryptophan-2-3-dioxygenase","display_name":"tryptophan 2,3-dioxygenase","score":0.8610000014305115},{"id":"https://openalex.org/keywords/aryl-hydrocarbon-receptor","display_name":"aryl hydrocarbon receptor","score":0.9319999814033508},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.7940000295639038},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.828000009059906},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8960000276565552},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6779999732971191},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C2777503454","wikidata":"https://www.wikidata.org/wiki/Q415768","display_name":"Kynurenine","level":4,"score":0.7175784707069397},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6832842826843262},{"id":"https://openalex.org/C96942376","wikidata":"https://www.wikidata.org/wiki/Q21130714","display_name":"Catabolism","level":3,"score":0.6325304508209229},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6276871562004089},{"id":"https://openalex.org/C83478079","wikidata":"https://www.wikidata.org/wiki/Q908221","display_name":"Indoleamine 2,3-dioxygenase","level":4,"score":0.5914561748504639},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5726397037506104},{"id":"https://openalex.org/C2908944834","wikidata":"https://www.wikidata.org/wiki/Q181003","display_name":"Tryptophan Metabolism","level":4,"score":0.47420981526374817},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4161229133605957},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4128798842430115},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3724655508995056},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34256747364997864},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3375225067138672},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3322966694831848},{"id":"https://openalex.org/C2776706248","wikidata":"https://www.wikidata.org/wiki/Q181003","display_name":"Tryptophan","level":3,"score":0.28193992376327515},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.21315813064575195},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19844871759414673},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.13837122917175293},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08901897072792053}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D007737","descriptor_name":"Kynurenine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014364","descriptor_name":"Tryptophan","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014366","descriptor_name":"Tryptophan Oxygenase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014366","descriptor_name":"Tryptophan Oxygenase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018336","descriptor_name":"Receptors, Aryl Hydrocarbon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050503","descriptor_name":"Indoleamine-Pyrrole 2,3,-Dioxygenase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D050503","descriptor_name":"Indoleamine-Pyrrole 2,3,-Dioxygenase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.3389/fimmu.2022.807271","doi":"https://doi.org/10.3389/fimmu.2022.807271","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2022.807271","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2022.807271/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8841724","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8841724/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:35173722","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35173722","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-04694443v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-04694443","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, 2022, 13, &#x27E8;10.3389/fimmu.2022.807271&#x27E9;","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:b475f8bccc534789898740487a8a2daa","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b475f8bccc534789898740487a8a2daa","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 13 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2022.807271","doi":"https://doi.org/10.3389/fimmu.2022.807271","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2022.807271","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2022.807271/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4212902132.pdf","grobid_xml":"https://content.openalex.org/works/W4212902132.grobid-xml"},"referenced_works_count":137,"referenced_works":["https://openalex.org/W1495607276","https://openalex.org/W1603640418","https://openalex.org/W1838472703","https://openalex.org/W1884284166","https://openalex.org/W1967885926","https://openalex.org/W1973251492","https://openalex.org/W1984678083","https://openalex.org/W1985443071","https://openalex.org/W1992248511","https://openalex.org/W1996613294","https://openalex.org/W1998142996","https://openalex.org/W2004522121","https://openalex.org/W2004630197","https://openalex.org/W2007316487","https://openalex.org/W2007489575","https://openalex.org/W2008343182","https://openalex.org/W2010378562","https://openalex.org/W2012836981","https://openalex.org/W2015260577","https://openalex.org/W2022430924","https://openalex.org/W2026429388","https://openalex.org/W2029458048","https://openalex.org/W2038234028","https://openalex.org/W2044104392","https://openalex.org/W2052006922","https://openalex.org/W2056036930","https://openalex.org/W2063436620","https://openalex.org/W2066352983","https://openalex.org/W2068912461","https://openalex.org/W2071120920","https://openalex.org/W2072078248","https://openalex.org/W2073563548","https://openalex.org/W2075094265","https://openalex.org/W2076927594","https://openalex.org/W2087801719","https://openalex.org/W2088492376","https://openalex.org/W2094967093","https://openalex.org/W2097049582","https://openalex.org/W2097156202","https://openalex.org/W2097615954","https://openalex.org/W2098921988","https://openalex.org/W2103553504","https://openalex.org/W2107312924","https://openalex.org/W2113325722","https://openalex.org/W2113906692","https://openalex.org/W2114017759","https://openalex.org/W2114601875","https://openalex.org/W2122285073","https://openalex.org/W2126932404","https://openalex.org/W2127903252","https://openalex.org/W2134123270","https://openalex.org/W2136731993","https://openalex.org/W2139027624","https://openalex.org/W2143565660","https://openalex.org/W2146339140","https://openalex.org/W2146934919","https://openalex.org/W2148196931","https://openalex.org/W2148801612","https://openalex.org/W2157027333","https://openalex.org/W2163946328","https://openalex.org/W2169417565","https://openalex.org/W2197798862","https://openalex.org/W2202295242","https://openalex.org/W2244492686","https://openalex.org/W2259545109","https://openalex.org/W2266683146","https://openalex.org/W2273004055","https://openalex.org/W2308639964","https://openalex.org/W2341631860","https://openalex.org/W2359306646","https://openalex.org/W2474061866","https://openalex.org/W2480979408","https://openalex.org/W2495814339","https://openalex.org/W2515296551","https://openalex.org/W2550992160","https://openalex.org/W2553568639","https://openalex.org/W2561550041","https://openalex.org/W2561926137","https://openalex.org/W2570766240","https://openalex.org/W2587048937","https://openalex.org/W2594368015","https://openalex.org/W2594615455","https://openalex.org/W2595109242","https://openalex.org/W2598111690","https://openalex.org/W2603408994","https://openalex.org/W2606250554","https://openalex.org/W2724690266","https://openalex.org/W2740628965","https://openalex.org/W2741102545","https://openalex.org/W2741228199","https://openalex.org/W2741627784","https://openalex.org/W2741787889","https://openalex.org/W2754918228","https://openalex.org/W2754961031","https://openalex.org/W2760638321","https://openalex.org/W2765314233","https://openalex.org/W2775687989","https://openalex.org/W2779643604","https://openalex.org/W2782774905","https://openalex.org/W2785278721","https://openalex.org/W2786095824","https://openalex.org/W2789740507","https://openalex.org/W2790897054","https://openalex.org/W2809832311","https://openalex.org/W2811342872","https://openalex.org/W2883967352","https://openalex.org/W2885602138","https://openalex.org/W2888312739","https://openalex.org/W2891429805","https://openalex.org/W2899358783","https://openalex.org/W2904882306","https://openalex.org/W2911968308","https://openalex.org/W2912593557","https://openalex.org/W2930154557","https://openalex.org/W2946859612","https://openalex.org/W2949375297","https://openalex.org/W2954696821","https://openalex.org/W2955093606","https://openalex.org/W2955395300","https://openalex.org/W2976621574","https://openalex.org/W3023756610","https://openalex.org/W3028368903","https://openalex.org/W3037276855","https://openalex.org/W3040791408","https://openalex.org/W3045946240","https://openalex.org/W3155318711","https://openalex.org/W3156533690","https://openalex.org/W3158441686","https://openalex.org/W3159850003","https://openalex.org/W3165380356","https://openalex.org/W3167687951","https://openalex.org/W3175617639","https://openalex.org/W3185386780","https://openalex.org/W3195602745","https://openalex.org/W4200495164","https://openalex.org/W4250008261","https://openalex.org/W4252294410"],"related_works":["https://openalex.org/W2993480792","https://openalex.org/W2777932404","https://openalex.org/W1838472703","https://openalex.org/W2097156202","https://openalex.org/W7117713071","https://openalex.org/W2912181843","https://openalex.org/W2054475219","https://openalex.org/W3123009177","https://openalex.org/W2612223042","https://openalex.org/W3133474211"],"abstract_inverted_index":{"Metabolism":[0],"of":[1,55,58,79,95,115,129,152,175,182,194],"tryptophan":[2,47],"(Trp),":[3],"an":[4],"essential":[5],"amino":[6],"acid,":[7],"represent":[8],"a":[9,30],"major":[10],"metabolic":[11],"pathway":[12,137],"that":[13,134,158,179],"both":[14],"promotes":[15],"tumor":[16],"cell":[17],"intrinsic":[18],"malignant":[19],"properties":[20],"as":[21,23,29,138,185,187],"well":[22,186],"restricts":[24],"antitumour":[25],"immunity,":[26],"thus":[27],"emerging":[28],"drug":[31],"development":[32],"target":[33,140,180],"for":[34],"cancer":[35],"immunotherapy.":[36,195],"Three":[37],"cytosolic":[38],"enzymes,":[39],"namely":[40],"indoleamine":[41],"2,3-dioxygenase":[42,48],"1":[43],"(IDO1),":[44],"IDO2":[45],"and":[46,63,86,155,165,189],"(TDO2),":[49],"catalyzes":[50],"the":[51,56,70,91,113,130,169,192],"first-rate":[52],"limiting":[53],"step":[54],"degradation":[57],"Trp":[59,131,183],"to":[60,101,162],"kynurenine":[61],"(Kyn)":[62],"modulates":[64],"immunity":[65],"toward":[66],"immunosuppression":[67],"mainly":[68],"through":[69],"aryl":[71],"hydrocarbon":[72],"receptor":[73],"(AhR)":[74],"activation":[75],"in":[76,141,191],"numerous":[77],"types":[78],"cancer.":[80],"By":[81],"restoring":[82],"antitumor":[83,177],"immune":[84,109],"responses":[85],"synergizing":[87],"with":[88,108],"other":[89],"immunotherapies,":[90],"encouraging":[92],"preclinical":[93],"data":[94],"IDO1":[96,153],"inhibitors":[97,154],"has":[98],"dramatically":[99],"failed":[100],"translate":[102],"into":[103],"clinical":[104,148],"success":[105],"when":[106],"combined":[107],"checkpoints":[110],"inhibitors,":[111],"reigniting":[112],"debate":[114],"combinatorial":[116],"approach.":[117],"In":[118],"this":[119,136,163],"review,":[120],"we":[121],"i)":[122],"provide":[123],"comprehensive":[124],"evidences":[125],"on":[126],"immunomodulatory":[127],"role":[128],"catabolism":[132,184],"metabolites":[133],"highlight":[135],"relevant":[139],"immuno-oncology,":[142],"ii)ii)":[143],"discuss":[144,168],"underwhelming":[145],"results":[146],"from":[147],"trials":[149],"investigating":[150],"efficacy":[151],"underlying":[156],"mechanisms":[157],"might":[159],"have":[160],"contributed":[161],"failure,":[164],"finally,":[166],"iii)":[167],"current":[170],"state-of-art":[171],"surrounding":[172],"alternative":[173],"approaches":[174],"innovative":[176],"immunotherapies":[178],"molecules":[181],"challenges":[188],"perspectives":[190],"era":[193]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4212902132","counts_by_year":[{"year":2026,"cited_by_count":32},{"year":2025,"cited_by_count":32},{"year":2024,"cited_by_count":38},{"year":2023,"cited_by_count":31},{"year":2022,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2022-02-24T00:00:00"}
